glp-1 vs glp vs. Peptide Therapy: What's the Difference—and Which Is Right for You? Indications for GLP-1/GIP RA Summary
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications approved by the FDA for managing type 2 diabetes and, in some formulations, for chronic weight management
These innovative treatments tackle the biological challenges of weight loss, helping you reach and sustain your goals
Rotate your injection site weekly
for example, semaglutide has a half-life of approximately 7 days based on the dosage used (Ushakumari and Sladen 2024
I knew I needed to make a change
